National Healthcare Corp NHC
We take great care to ensure that the data presented and summarized in this overview for NATIONAL HEALTHCARE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHC
View all-
Black Rock Inc. New York, NY2.09MShares$263 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$194 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.01MShares$127 Million0.03% of portfolio
-
Morgan Stanley Institutional Investment Advisors LLC Greenwood Village, CO780KShares$98.2 Million22.05% of portfolio
-
State Street Corp Boston, MA494KShares$62.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny391KShares$49.2 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA292KShares$36.8 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA196KShares$24.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL185KShares$23.3 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA160KShares$20.2 Million0.0% of portfolio
Latest Institutional Activity in NHC
Top Purchases
Top Sells
About NHC
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.
Insider Transactions at NHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
2,307
-100.0%
|
-
|
Sep 04
2024
|
Brian F Kidd SVP, Controller, PAO |
SELL
Open market or private sale
|
Direct |
2,000
-8.42%
|
$260,000
$130.01 P/Share
|
Aug 14
2024
|
Stephen Fowler Flatt CEO |
SELL
Open market or private sale
|
Direct |
3,907
-6.41%
|
$492,282
$126.54 P/Share
|
Aug 14
2024
|
James Paul Abernathy Director |
SELL
Open market or private sale
|
Direct |
1,605
-4.6%
|
$203,835
$127.0 P/Share
|
Aug 13
2024
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,000
+24.84%
|
$213,000
$71.64 P/Share
|
Jun 12
2024
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,799
-29.44%
|
$288,297
$103.61 P/Share
|
Jun 12
2024
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+29.61%
|
$212,000
$53.94 P/Share
|
Jun 12
2024
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
2,350
-75.32%
|
-
|
Jun 11
2024
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
50
-100.0%
|
-
|
May 31
2024
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-7.52%
|
$79,800
$105.75 P/Share
|
May 17
2024
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,776
-2.83%
|
$177,600
$100.4 P/Share
|
May 17
2024
|
Stephen Fowler Flatt CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+3.83%
|
$132,500
$53.94 P/Share
|
May 07
2024
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+2.78%
|
$577,500
$77.92 P/Share
|
May 03
2024
|
Emil E Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.31%
|
$577,500
$77.92 P/Share
|
May 01
2024
|
Ernest G Burgess Iii Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
6,350
-6.86%
|
$584,200
$92.02 P/Share
|
May 01
2024
|
Ernest G Burgess Iii Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+7.5%
|
$577,500
$77.92 P/Share
|
Apr 30
2024
|
Richard F Laroche Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,001
-1.47%
|
$270,090
$90.87 P/Share
|
Apr 30
2024
|
Richard F Laroche Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+100.0%
|
$577,500
$77.92 P/Share
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,257
-2.07%
|
$312,672
$96.48 P/Share
|
Mar 12
2024
|
Robert Michael Ussery President & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+2.78%
|
$238,500
$53.94 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 147K shares |
---|---|
Grant, award, or other acquisition | 11.5K shares |
Payment of exercise price or tax liability | 99.4K shares |
---|---|
Other acquisition or disposition | 2.31K shares |
Open market or private sale | 22.5K shares |
Bona fide gift | 6.1K shares |